Related Experiment Video
Updated: Apr 15, 2026

10:11
Updated Technique for Reliable, Easy, and Tolerated Transcranial Electrical Stimulation Including Transcranial Direct Current Stimulation
Published on: January 3, 2020
12.1K
Transcranial direct current stimulation as a treatment for auditory hallucinations
Sanne Koops1, Hilde van den Brink1, Iris E C Sommer1
1Psychiatry Department, Brain Center Rudolf Magnus, University Medical Center Utrecht Utrecht, Netherlands.
Frontiers in Psychology
|March 24, 2015
Summary
Transcranial direct current stimulation (tDCS) offers a new, non-invasive approach for treating auditory hallucinations (AH) resistant to medication. This technique modulates brain activity, showing promise where traditional treatments fail.
Area of Science:
- Neuroscience
- Psychiatry
- Neuromodulation
Background:
- Auditory hallucinations (AH) are a common symptom in psychiatric disorders like schizophrenia.
- A significant portion of patients with AH do not respond adequately to antipsychotic medications.
- Current treatment options for medication-resistant AH are limited, often focusing on coping strategies rather than symptom reduction.
Purpose of the Study:
- To review the current knowledge on transcranial direct current stimulation (tDCS) for treating auditory hallucinations.
- To explore tDCS as a potential alternative treatment for medication-resistant AH.
- To provide guidelines for future research in this emerging therapeutic area.
Main Methods:
- Transcranial direct current stimulation (tDCS) involves applying low electric currents (1-2 mA) via surface electrodes to modulate cortical excitability.
- Anodal stimulation increases excitability, while cathodal stimulation decreases it.
- The review synthesizes existing literature on tDCS efficacy in various neurological and psychiatric conditions.
Main Results:
- tDCS is a safe, non-invasive, cost-effective, and portable neuromodulation technique.
- The method has demonstrated efficacy in treating symptoms across a range of conditions including depression, bipolar disorder, schizophrenia, and neurodegenerative diseases.
- Its application for auditory hallucinations is a relatively new but promising field of investigation.
Conclusions:
- tDCS presents a viable and emerging therapeutic option for individuals experiencing medication-resistant auditory hallucinations.
- Further research is warranted to establish optimal protocols and confirm efficacy specifically for AH.
- This technique holds potential to significantly improve treatment outcomes for a challenging patient group.

